Clinical News: Page 408

MILabs receives Isreali contract

By AuntMinnieEurope.com staff writers

Preclinical imaging developer MILabs has taken an order for its Vector PET/SPECT/CT from Tel Aviv University's new Translational Medicine Center.

July 8, 2019

Varian delivers TrueBeam to IAEA facility in Austria

By AuntMinnieEurope.com staff writers

Radiation therapy firm Varian Medical Systems has installed its TrueBeam radiotherapy system at the International Atomic Energy Agency (IAEA) Dosimetry Laboratory in Seibersdorf, Austria.

July 8, 2019

Gadolinium safety controversy resurfaces in Germany

By AuntMinnieEurope.com staff writers

The use of gadolinium-based contrast agents for MRI exams is the centerpiece of an article published on 6 July in the popular German news magazine Der Spiegel.

July 8, 2019

Point-of-care ultrasound pays off in rural Germany

By Philip Ward

In remote parts of Germany, point-of-care ultrasound is enabling doctors to provide faster and more accurate diagnoses and treatments to patients in the community, helping to reduce hospital stays and the financial cost for the health system, particularly among the elderly.

July 8, 2019

Bruker acquires preclinical, molecular software provider

By AuntMinnieEurope.com staff writers

MRI developer Bruker has acquired preclinical and molecular imaging software firm PMOD Technologies. Details of the transaction were not disclosed.

July 7, 2019

Bracco gets set to acquire Blue Earth Diagnostics

By Wayne Forrest

Contrast manufacturer Bracco Imaging is moving ahead with its plan to acquire molecular imaging company Blue Earth Diagnostics for over 390 million euros, with an additional closing adjustment estimated at 22 million euros. The deal is likely to be completed in the autumn.

July 7, 2019

Germans use spectroscopy to cut beam-range uncertainty

By Marric Stephens

German scientists are convinced that measuring the energy of gamma rays emitted during helium-ion radiotherapy can provide real-time verification of the beam's range in the patient. They have shown how to define the size of the range error in particle therapy, allowing more precise treatments with greater sparing of healthy tissue.

July 4, 2019

Which imaging modality is best for ovarian cancer?

By Philip Ward

FDG-PET/CT is more accurate than contrast-enhanced CT for detecting primary ovarian cancer, but due to CT's wide availability, cost-effectiveness, and quick interpretation by junior radiologists, it is preferred on a daily basis, attendees learned at the recent World Congress on obstetrics and gynecology in London.

July 3, 2019

Breast cancer screening develops in Iran

By AuntMinnieEurope.com staff writers

Breast cancer screening tests and prevention services in Iran are now covered by a universal public health insurance plan, according to a 3 July report in the Tehran Times.

July 2, 2019

Irish fears grow over litigation's impact on screening

By Philip Ward

There's a significant risk doctors won't work in Ireland's breast cancer screening service due to fears over being sued for false-negative results, according to a national newspaper article published on 2 July. The future of the service is now in jeopardy, leading experts warn.

July 2, 2019

Telix signs distribution agreement with Turkish firm

By AuntMinnieEurope.com staff writers

Telix Pharmaceuticals has signed a distribution agreement with Eczacıbaşı-Monrol of Istanbul.

July 2, 2019

3D-printed guides optimize pelvic tumor surgery

By Abraham Kim

Using 3D-printed surgical guides based on CT scans enabled researchers from Spain to improve the accuracy of, and potentially reduce operating times for, the surgical removal of pelvic tumors in a new study, presented at the recent Computer Assisted Radiology and Surgery 2019 congress in Rennes, France.

July 2, 2019

Previous Page

Page 408 of 1295

Next Page